Dr Agarwals Eye Hospital Limited strategy deck summary

Strategy deck of 27 Aug 2025, summarised by AI from the filing.

Boards of AHCL and AEHL approved merger of AEHL with AHCL, expected to complete by Q2 FY27 subject to regulatory approvals.

Key takeaways

1. Merger Boards of AHCL and AEHL approved merger of AEHL with AHCL, creating a single listed entity housing all Dr. Agarwal's operations.
2. Share exchange AEHL shareholders other than AHCL will get 23 AHCL shares for every 2 AEHL shares, a 15% premium to AEHL's 10-day VWAP.
3. Preferential issue AEHL proposes a preferential allotment of ₹70 cr to AHCL at ₹5,270 per share, about 2.7% of post-issue capital, to finance ongoing capex.

Original filing on BSE

Dr Agarwals Eye Hospital Limited earnings call, investor presentation and press release summaries

• Other events: Strategy deck (27 Aug 2025)